MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ROBINSON, C. H.
Right arrow Articles by FISHER, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ROBINSON, C. H.
Right arrow Articles by FISHER, J.

Molecular Pharmacology, Vol 6, 604-616, Copyright © 1970 by the American Society for Pharmacology and Experimental Therapeutics

Relationship between Structure, Conformation, and Antischistosomal Activity of Nitroheterocyclic Compounds

C. H. ROBINSON 1, E. BUEDING 1, and J. FISHER 1

1 Department of Pharmacology and Experimental Therapeutics, School of Medicine, and Department of Pathobiology, School of Hygiene and Public Health, The Johns Hopkins University, Baltimore, Maryland 21205

The biochemical and chemotherapeutic effects of a number of nitroheterocyclic compounds, including niridazole [1-(5-nitro-2-thiazolyl)-2-imidazolidinone] and some 5-nitro-2-furyl derivatives, on Schistosoma mansoni were investigated. Those compounds which had marked schistosomicidal activity had common structural and conformational features. These comprised a 5-nitrothiazolyl or 5-nitrofuryl ring, with a nitrogen substituent (generally part of an amide or oxadiazole system) attached to C-2 via a rigid side chain. The latter contains either a C=C double bond or a nitrogen atom attached directly to C-2 of the heterocyclic ring. These features, which are illustrated in the accompanying structure, are believed to be

See PDF for Equation

essential for significant antischistosomal activity. The schistosomicidal effects of compounds of this structural type were invariably preceded by a reduction of phosphorylase phosphatase activity in the worms, suggesting a common mode of action.

Note:
ACKNOWLEDGMENTS We are indebted to Dr. Arnold D. Welch of the Squibb Institute for Medical Research and to Dr. Herman Breuer of the Heyden Chemical Company for the nitrofurans, to Dr. Ashton C. Cuckler and Dr. William C. Campbell of Merck and Company for aminitrozole, to Dr. Edward F. Elslager of Parke, Davis and Company for the nitrosonaphthylamine, as well as to all of the above for the mouse diets in which many of these compounds had been incorporated, to Dr. Gerald Berkelhammer of American Cyanamid Company for the pyridine- and quinoline-substituted nitrothiazoles, and to Miss Geraldine Rose and Miss Mary Pyles for valuable technical assistance.

Submitted on July 7, 1970




This article has been cited by other articles:


Home page
ScienceHome page
S. H. Rogers and E. Bueding
Hycanthone Resistance: Development in Schistosoma mansoni
Science, June 4, 1971; 172(3987): 1057 - 1058.
[Abstract] [PDF]


Home page
ScienceHome page
P. E. Hartman, K. Levine, Z. Hartman, and H. Berger
Hycanthone: A Frameshift Mutagen
Science, June 4, 1971; 172(3987): 1058 - 1060.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1970 by the American Society for Pharmacology and Experimental Therapeutics